AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 Jul 2010 09:00 AM
RNS
Notice of Results
27 Jul 2010 07:00 AM
RNS
FDA Briefing Materials for Br
02 Jul 2010 01:00 PM
RNS
Holding(s) in Company
01 Jul 2010 04:30 PM
RNS
Director/PDMR Shareholding
01 Jul 2010 04:00 PM
RNS
Total Voting Rights
30 Jun 2010 07:00 AM
RNS
Crestor patent upheld by US c
30 Jun 2010 07:00 AM
RNS
Transaction in Own Shares
29 Jun 2010 07:00 AM
RNS
Transaction in Own Shares
25 Jun 2010 07:00 AM
RNS
Transaction in Own Shares
25 Jun 2010 07:00 AM
RNS
FDA resets its decision date
24 Jun 2010 07:00 AM
RNS
Transaction in Own Shares
23 Jun 2010 07:00 AM
RNS
Transaction in Own Shares
17 Jun 2010 07:00 AM
RNS
Canadian court rules on esome
17 Jun 2010 07:00 AM
RNS
Transaction in Own Shares
16 Jun 2010 07:00 AM
RNS
Transaction in Own Shares
09 Jun 2010 07:00 AM
RNS
Transaction in Own Shares
08 Jun 2010 07:00 AM
RNS
Transaction in Own Shares
04 Jun 2010 07:00 AM
RNS
Submission to EU for cardiova
03 Jun 2010 07:00 AM
RNS
FDA AdCom reviews motavizumab
01 Jun 2010 04:00 PM
RNS
Total Voting Rights
01 Jun 2010 07:00 AM
RNS
AstraZeneca Receives CRL for
01 Jun 2010 07:00 AM
RNS
Transaction in Own Shares
28 May 2010 07:00 AM
RNS
Recentin Horizon II Results
28 May 2010 07:00 AM
RNS
Transaction in Own Shares
27 May 2010 07:00 AM
RNS
Transaction in Own Shares
26 May 2010 01:45 PM
RNS
Martin Mackay to head AstraZe
26 May 2010 07:00 AM
RNS
Transaction in Own Shares
25 May 2010 05:00 PM
RNS
Filing of AGM Resolutions
25 May 2010 04:00 PM
RNS
Director/PDMR Shareholding
25 May 2010 07:00 AM
RNS
Transaction in Own Shares
24 May 2010 07:00 AM
RNS
Transaction in Own Shares
21 May 2010 07:00 AM
RNS
Transaction in Own Shares
20 May 2010 07:00 AM
RNS
Transaction in Own Shares
19 May 2010 07:00 AM
RNS
Transaction in Own Shares
18 May 2010 07:00 AM
RNS
AZ agreement with Teva on Ent
18 May 2010 07:00 AM
RNS
Transaction in Own Shares
17 May 2010 07:00 AM
RNS
Transaction in Own Shares
14 May 2010 07:00 AM
RNS
Transaction in Own Shares
13 May 2010 07:00 AM
RNS
Transaction in Own Shares
12 May 2010 07:00 AM
RNS
Transaction in Own Shares
11 May 2010 07:00 AM
RNS
Transaction in Own Shares
10 May 2010 05:00 PM
RNS
Director/PDMR Shareholding
10 May 2010 05:00 PM
RNS
Director/PDMR Shareholding
10 May 2010 07:00 AM
RNS
Transaction in Own Shares
07 May 2010 07:00 AM
RNS
Transaction in Own Shares
06 May 2010 07:00 AM
RNS
Transaction in Own Shares
05 May 2010 07:00 AM
RNS
Transaction in Own Shares
04 May 2010 04:30 PM
RNS
Director Declaration
04 May 2010 04:00 PM
RNS
Total Voting Rights
04 May 2010 07:00 AM
RNS
VIMOVO approved by US FDA
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100